CVI Holdings’s AEON Biopharma Inc AEON.WS Stock Holding History

CVI Holdings’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-78,674	Closed	-$4.33K	–	345
2023 Q1	$4.33K	Sell	78,674 -28,935	-27%	-$1.67K	﹤0.01%	331
2022 Q4	$4.91K	Sell	107,609 -33,144	-24%	-$1.34K	﹤0.01%	441
2022 Q3	$7K	Hold	140,753	–	–	﹤0.01%	669
2022 Q2	$21K	Hold	140,753	–	–	﹤0.01%	623
2022 Q1	$39K	Sell	140,753 -25,913	-16%	-$10.7K	﹤0.01%	669
2021 Q4	$85K	Hold	166,666	–	–	0.01%	670
2021 Q3	$92K	Hold	166,666	–	–	0.01%	652
2021 Q2	$167K	Buy	+166,666	New	+$126K	0.01%	504

Other funds holding AEON.WS

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

CVI Holdings's AEON.WS Position: Q2 2023 in Review

CVI Holdings sold out of AEON Biopharma Inc (AEON.WS) in Q2 2023, closing a stake of 78,674 shares — an estimated $4.33K sold.

CVI Holdings first reported a position in AEON.WS in Q2 2021 and held it in 8 quarters. The position peaked at $167K in Q2 2021. 42 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2023.

CVI Holdings reported no remaining AEON Biopharma Inc position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 78,674 AEON Biopharma Inc shares in Q2 2023, an estimated $4.33K.
CVI Holdings first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 8 quarters.
CVI Holdings's AEON Biopharma Inc position peaked at $167K in Q2 2021.
42 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.